BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | – | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2014 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2014 | $4,000 | – | 1,000 | 0.0% | 0.00% | – |
Q2 2014 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q1 2014 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2013 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2013 | $3,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Amici Capital, LLC | 8,000,000 | $53,880,000 | 1.96% |
Baker Brothers Advisors | 22,379,000 | $149,970,000 | 1.32% |
GEODE CAPITAL MANAGEMENT, LLC | 1,000,000 | $6,732,000 | 0.00% |
UBS Group AG | 22,000 | $148,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,000 | $13,000 | 0.00% |
MORGAN STANLEY | 14,000 | $94,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 1,000 | $7,000 | 0.00% |
ROYAL BANK OF CANADA | 2,000 | $12,000 | 0.00% |